Symbol="ACLX"
AssetType="Common Stock"
Name="Arcellx Inc"
Description="Arcellx, Inc., a clinical-stage biotechnology company, is engaged in the development of various immunotherapies for patients with cancer and other incurable diseases. The company is headquartered in Gaithersburg, Maryland."
CIK="1786205"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="25 WEST WATKINS MILL ROAD, SUITE A, GAITHERSBURG, MD, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1689180000"
EBITDA="-192268992"
PERatio="None"
PEGRatio="None"
BookValue="6.08"
DividendPerShare="0"
DividendYield="0"
EPS="-4.36"
RevenuePerShareTTM="0.705"
ProfitMargin="0"
OperatingMarginTTM="-6.02"
ReturnOnAssetsTTM="-0.243"
ReturnOnEquityTTM="-0.593"
RevenueTTM="32213000"
GrossProfitTTM="0"
DilutedEPSTTM="-4.36"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="50.7"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="6.12"
EVToRevenue="-"
EVToEBITDA="-7.34"
Beta="None"
num_52WeekHigh="48.91"
num_52WeekLow="15.63"
num_50DayMovingAverage="33.88"
num_200DayMovingAverage="32.43"
SharesOutstanding="48359000"
DividendDate="None"
ExDividendDate="None"
symbol="ACLX"
open="35.12"
high="35.39"
low="34.48"
price="34.93"
volume="317642.00"
latest_trading_day="2023-08-24"
previous_close="35.20"
change="-0.27"
change_percent="-0.7670%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="42"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="58"
Volume_recent_avg="568973"
Change_recent_avg="0.04"
Delta_recent_avg="1.88"
Variance_recent_avg="0.94"
Change_ratio_recent_avg="0.09"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="58"
Aroon_momentum_negative="42"
image_negative_thumbnail_id_1="113"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0063.jpeg"
image_negative_thumbnail_id_2="137"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0039.jpeg"
image_neutral_thumbnail_id_1="541"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0058.jpeg"
image_neutral_thumbnail_id_2="575"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0024.jpeg"
image_positive_thumbnail_id_1="674"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0034.jpeg"
image_positive_thumbnail_id_2="619"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0089.jpeg"
image_professor_thumbnail_id_1="1180"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0014.jpeg"
image_professor_thumbnail_id_2="1177"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0011.jpeg"
